Prognostic value of ambulatory blood pressure: Current evidence and clinical implications

Hypertension

Volumn 35, Issue 3, 2000, Pages 844-851

  Verdecchia, Paolo ^a  

^a Ospedale Silvestrini   (Italy)

Author keywords

Blood pressure monitoring; Hypertension, arterial; Hypertension, essential; Hypertension, white coat; Myocardial infarction; Stroke

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; ESSENTIAL HYPERTENSION; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; STROKE; WHITE COAT HYPERTENSION;

EID: 0034019988     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.844     Document Type: Article

References (92)

1. Pickering T, for an American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens. 1996;9:1-11.
2. Mallion J-M, Baguet J-P, Siché J-P, Tremel F, De Gaudemaris R. Clinical value of ambulatory blood pressure monitoring. J Hypertens. 1999;17: 585-595.
3. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA. 1983;249:2792-2798.
4. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens. 1989;7(suppl 3):S3-S10.
5. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
6. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Porcellati C. Nocturnal pressure is the true pressure. Blood Press Monit. 1996; 1(suppl 2):S81-S85.
7. Verdecchia P, Borgioni C, Ciucci A, Gattobigio RP, Schillaci G, Sacchi N, Santucci A, Santucci C, Reboldi G, Porcellati C. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit. 1996;1:3-11.
8. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. Prognostic significance of the white-coat effect. Hypertension. 1997;29:1218-1224.
9. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Telera MP, Pede S, Gattobigio R, Porcellati C. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. J Hypertens. 1998; 16:1335-1343.
10. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension. 1998;32:983-988.
11. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Guerrieri M, Comparato E, Benemio G, Porcellati C. Altered circadian blood pressure profile and prognosis. Blood Press Monit. 1997;2:347-352.
12. Verdecchia P, Schillaci G, Gatteschi C, Zampi I, Battistelli M, Bartoccini C, Porcellati C. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation. 1993;88: 986-992.
13. Pickering TG, James GD. Ambulatory blood pressure and prognosis. J Hypertens. 1994;12(suppl 8):S29-S33.
14. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10 year follow-up study. Circulation. 1998;98:1982-1987.
15. Zweiker R, Eber B, Schumacher M, Toplak H, Klein W. "Non dipping" related to cardiovascular events in essential hypertensive patients. Acta Med Austriaca. 1994;21:86-89.
16. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282: 539-546.
17. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kimura J. Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke. 1998;29:570-576.
18. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998;31:712-718.
19. Imai Y, Ohkubo T, Tsuji I, Nagai K, Satoh H, Hisamichi S, Abe K. Prognostic value of ambulatory and home blood pressure measurements in comparison to screening blood pressure measurements: a pilot study in Ohasama. Blood Press Monit. 1996;1(suppl 2):S51-S58.
20. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Itoh O, Bando T, Sakuma M, Fukao A, Satoh H, Hisamichi, Abe K. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15:357-364.
21. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Satoh H. Relation between nocturnal decline in blood pressure and mortality: the Ohasama study. Am J Hypertens. 1997;10:1201-1207.
22. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension. Lancet. 1996;348:1444-1445.
23. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. Reversed circadian blood pressure rhythm is associated with occurrence of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes. 1998;47:1501-1506.
24. Staessen JA, Bieniaszewski L, O'Brien ET, Imai Y, Fagard R. An epidemiological approach to ambulatory blood pressure monitoring: the Belgian population study. Blood Press Monit. 1996;1:13-26.
25. Clement DL, De Buyzere M, Duprez D. Ambulatory blood pressure and prognosis: summary of ongoing studies. J Hypertens. 1991;9(suppl 8):S51-S53.
26. Zanchetti A, Bond G, Henning M, Neiss A, Mancia G, Dal Palù C, Hannson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R, on behalf of the ELSA Investigators. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1988;16:949-961.
27. Brown MJ, Castaigne A, Ruilope LM, Mancia G, Rosenthal T, de Leeuw PW, Ebner F. INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment. J Hum Hypertens. 1996;10(suppl 3):S157-S160.
28. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
29. Guidelines Subcommittee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
30. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white-coat hypertension? JAMA. 1988;259:225-228.
31. White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office pressure, determines cardiac function in patients with hypertension. JAMA. 1989;261:873-877.
32. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of "normal" ambulatory blood pressure: implications in the assessment of white-coat hypertension. Hypertension. 1992;20:555-562.
33. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, Mezzetti A. Target organ status and serum lipids in patients with white-coat hypertension. Hypertension. 1995;26:801-807.
34. Kuwajima I, Miyao M, Uno A, Suzuki Y, Matsushita S, Kuramoto K. Diagnostic value of electrocardiography and echocardiography for white-coat hypertension in the elderly. Am J Cardiol. 1994;73: 1232-1234.
35. Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white-coat hypertension. Hypertension. 1993;21:836-844.
36. Cerasola G, Cottone S, Nardi E, D'Ignoto G, Volpe V, Mulè G, Carollo C. White-coat hypertension and cardiovascular risk. J Cardiovasc Risk. 1995;2:545-549.
37. Glen SK, Elliot HL, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet. 1996;348: 654-657.
38. Siegel WC, Blumenthal JA, Divine GW. Physiological, psychological and behavioral factors and white-coat hypertension. Hypertension. 1990; 16:140-146.
39. Weber MA, Neutel JM, Smith DHG, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation. 1994;90:2291-2298.
40. Hoegholm A, Kristensen KS, Bang LE, Nielsen JW, Nielsen WB, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white-coat hypertension. Am J Hypertens. 1993; 6:282-286.
41. Marchesi E, Perani G, Falaschi F, Negro C, Catalano O, Ravetta V, Finardi G. Metabolic risk factors in white-coat hypertensives. J Hum Hypertens. 1994;8:475-479.
42. Bidlingmeyer I, Burier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens. 1996; 14:327-332.
43. Rizzo V, Cicconetti P, Bianchi A, Lorido A, Morelli S, Vetta F, Salza MC, Marigliano V. White-coat hypertension and cardiac organ damage in elderly subjects. J Hum Hypertens. 1996;10:293-298.
44. Trenkwalder P, Plaschke M, Steffes-Tremer I, Lydtin H. "White-coat" hypertension and alerting reaction in elderly and very elderly hypertensive patients. Blood Press. 1993;2:262-271.
45. Staessen J, O'Brien E, Atkins N, Amery A. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens. 1993;11:1289-1297.
46. Amar J, Bieler L, Salvador M, Chamontin B. Intima-media thickness of carotid artery in white-coat and ambulatory hypertension. Arch Mal Coeur Vaiss. 1997;90:1075-1078.
47. Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, Leonetti G, Zanchetti A. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension. J Hypertens. 1995; 13:1707-1711.
48. Polonia JJ, Santos AR, Gama GM, Basto F, Bettencourt PM, Martins LR. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years). Blood Press Monit. 1997;2:289-295.
49. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension: not guilty when correctly defined. Blood Press Monit. 1998;3:147-152.
50. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
51. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
52. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G, Porcellati C. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation. 1998;97:48-54.
53. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13:1377-1390.
54. Hunyor SN, Flynn JM, Cochineas C. Comparison of performance of various sphygmomanometers with intra-arterial blood pressure recordings. BMJ. 1978;2:159-162.
55. Pickering TG. White coat hypertension: time for action. Circulation. 1998;97:1834-1836.
56. Riva Rocci S. La tecnica della sfigmomanometria. Gazzetta Med Torino. 1897;10:181-191.
57. Ayman D, Goldshine AD. Blood pressure determinations by patients with essential hypertension: the difference between clinic and home readings before treatment. Am J Med Sci. 1940;200:465-474.
58. Mancia G, Bertineri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A. Effects of blood pressure measured by the doctor on patient's blood pressure and heart rate. Lancet. 1983;2: 695-698.
59. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension. 1987;9:209-215.
60. Pickering TG. White-coat hypertension in a changing era of medical care. Blood Press Monit. 1996;1(suppl 2):S27-S32.
61. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. The difference between clinic and daytime blood pressure is not a measure of the "white-coat effect." Hypertension. 1998;31:1185-1189.
62. Littler WA, West MJ, Honour AJ, Sleight P. The variability of arterial pressure. Am Heart J. 1978;95:180-186.
63. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53:96-104.
64. van Ittersum FJ, Ijzerman RG, Stehouwer CDA, Donker AJM. Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens. 1995;13:1053-1058.
65. Fagard R, Brguljan J, Thijs L, Staessen J. Prediction of the actual awake and asleep blood pressures by various methods of 24h pressure analysis. J Hypertens. 1996;14:557-563.
66. Pickering TG. How should the diurnal changes of blood pressure be expressed? Am J Hypertens. 1995;8:681-682.
67. Parati G, Pomidossi G, Casadei R, Malaspina D, Colombo A, Ravogli A, Mancia G. Ambulatory blood pressure does not interfere with the haemodynamic effects of sleep. J Hypertens. 1985;3(suppl 2):S107-S109.
68. Brigden G, Broadhurst P, Cashman P, Raftery E. Effects of non-invasive ambulatory blood pressure devices on blood pressure. Am J Cardiol. 1991;66:1396-1398.
69. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2:397.
70. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528-536.
71. Verdecchia P, Porcellati C. Day-night changes of ambulatory blood pressure: another risk marker in essential hypertension? G Ital Cardiol. 1992; 22:879-886. In Italian.
72. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens. 1992; 5:180-186.
73. Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J. 1992;67:1307-1311.
74. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, Pessina AC. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med. 1992;152: 1855-1860.
75. Schmieder RE, Rockstroh JK, Äpfelbacher F, Schulze B, Messerli FH. Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am J Hypertens. 1995;8:1160-1166.
76. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992;10: 875-878.
77. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive subjects: advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130-135.
78. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens. 1994;12:947-953.
79. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:23-29.
80. Timio M, Venanzi S, Lolli S, Lippi C, Verdura E, Guerrini E, Monarca C. Night-time blood pressure and progression of renal insufficiency. High Blood Press Cardiovasc Prev. 1994;3:39-44.
81. Fagard RH, Staessen JA, Thijs L. The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens. 1995;13:823-829.
82. Porcellati C, Schillaci G, Verdecchia P, Battistelli M, Bartoccini C, Zampi I, Guerrieri M, Comparato E. Diurnal blood pressure changes and left ventricular mass: influence of daytime blood pressure. High Blood Press Cardiovasc Prev. 1993;2:249-258.
83. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertension. 1987;5:93-98.
84. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C. Lack of association between blood pressure variability and left ventricular mass in essential hypertension. Am J Hypertens. 1998;11:515-522.
85. Floras JS, Hassan MO, Vann Jones J, Osikowska BA, Sever PS, Sleight P. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension. 1988;11:273-281.
86. Palatini P, Julius S. Heart rate and cardiovascular risk. J Hypertens. 1997;15:3-17.
87. Palatini P. Need for a revision of the normal limits of resting heart rate. Hypertension. 1999;33:622-625.
88. Dyer AR, Stamler J, Shekelle RB, Schoenberger JA, Stamler R, Shekelle S, Collette P, Berkson DM, Paul O, Lepper MH, Lindberg HA. Pulse pressure, III: prognostic significance in four Chicago epidemiological studies. J Chron Dis. 1982;35:283-294.
89. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395-401.
90. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard J-L, Ducimetière P. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997;30:1410-1415.
91. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354-360.
92. NHS Research and Development Centre for Evidence Based Medicine. Levels of evidence and grades of recommendations (revised on 17th September 1998). Web site: http://cebm.jr2.ox.ac.uk/docs/levels.html